Loading…
Mereo BioPharma Group plc is projected to rise to $0.3488 by 2027, a +11% move from its current price of $0.3155. MREO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.3045 | $0.3157 | $0.3273 | +0.07% |
| Aug 6 | $0.3002 | $0.3159 | $0.3325 | +0.14% |
| Aug 7 | $0.297 | $0.3162 | $0.3366 | +0.21% |
| Aug 8 | $0.2944 | $0.3164 | $0.3401 | +0.28% |
| Aug 9 | $0.2921 | $0.3166 | $0.3432 | +0.36% |
| Aug 10 | $0.29 | $0.3168 | $0.3461 | +0.43% |
| Aug 11 | $0.2882 | $0.3171 | $0.3488 | +0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2882 | $0.3171 | $0.3488 | +0.50% |
| Week 2 | $0.2784 | $0.3187 | $0.3647 | +1.00% |
| Week 3 | $0.2714 | $0.3202 | $0.3778 | +1.50% |
| Week 4 | $0.2659 | $0.3218 | $0.3896 | +2.01% |
| Week 5 | $0.2612 | $0.3234 | $0.4004 | +2.52% |
| Week 6 | $0.2573 | $0.3251 | $0.4107 | +3.03% |
| Week 7 | $0.2537 | $0.3267 | $0.4206 | +3.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mereo BioPharma Group plc is a biopharmaceutical company focused on developing and commercializing therapeutics for rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency associated lung disease; and Vantictumab, an anti-FZD monoclonal antibody for the treatment of autosomal dominant osteopetrosis type 2. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom.
Mereo BioPharma Group plc (MREO) is trading with a current price of $0.3427 and a market capitalization of $54.7M. The stock is ranked 4454 by market cap in the available set. The forecast suggests a gradual upside over the coming years, with the 2026 average price at $0.3427 rising to higher levels in subsequent years, including $0.5461 by 2030 and a long-run path toward higher levels through 2050.
The implied upside culminates in a 2050 average of $2.52 with a max of $5.20, implying a potential long-run uplift to sizable gains.
A major floor 24.9% below — a decisive break under it would weaken the trend.
The nearest floor, 8.7% below — buyers have tended to step in here.
The nearest ceiling, 8.7% above — a clean break opens room to run.
A major ceiling 20.3% above — clearing it would confirm fresh momentum.
Key MREO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MREO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3152 | Buy | $0.3193 | Sell |
| MA 10 | $0.3064 | Buy | $0.3137 | Buy |
| MA 20 | $0.3144 | Buy | $0.3126 | Buy |
| MA 50 | $0.3136 | Buy | $0.3169 | Sell |
| MA 100 | $0.3128 | Buy | $0.4087 | Sell |
| MA 200 | $0.7771 | Sell | $0.7597 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.30 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 168.28 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 4.57 | Buy |
| Bollinger %B (20,2) | 1.01 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.04 | Sell |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 71.63 | Sell |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 0.32 | Sell |
| ADX (14) | 8.96 | Neutral |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is described as BULLISH in sentiment. The RSI14 is 60, with the SMA50 at $0.3136 and the SMA200 at $0.7771, highlighting a near-term positive bias versus the longer-term trend. Support is identified at $0.288 and resistance at $0.343, giving a defined trading range in the near term.
The 30-day range spans from $0.2701 to $0.4348, indicating room for upside before resistance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.237 | $0.3155 | $0.4446 | 0% | Neutral | |
| $0.2701 | $0.3488 | $0.4807 | +11% | Neutral | |
| $0.2728 | $0.3661 | $0.5293 | +16% | Neutral | |
| $0.2858 | $0.3961 | $0.5941 | +26% | Bullish | |
| $0.3543 | $0.5054 | $0.7815 | +60% | Bullish | |
| $0.3949 | $0.5784 | $0.9184 | +83% | Bullish | |
| $0.4114 | $0.6175 | $1.00 | +96% | Bullish | |
| $0.4398 | $0.6757 | $1.12 | +114% | Bullish | |
| $0.3949 | $0.6203 | $1.05 | +97% | Bullish | |
| $0.4099 | $0.6578 | $1.13 | +109% | Bullish | |
| $0.5323 | $0.943 | $1.75 | +199% | Bullish | |
| $1.10 | $2.33 | $4.82 | +638% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.237 | $0.3155 | $0.3964 | +0.00% |
| September 2026 | $0.2862 | $0.3415 | $0.4211 | +8.23% |
| October 2026 | $0.2795 | $0.3366 | $0.421 | -1.42% |
| November 2026 | $0.2759 | $0.3348 | $0.4235 | -0.53% |
| December 2026 | $0.2848 | $0.3479 | $0.4446 | +3.92% |
Click any year to see its month-by-month MREO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, MREO is projected to trade between $0.237 and $0.4446, averaging $0.3155 — a potential gain of 0% from today's $0.3155. Price action looks broadly range-bound.
Mereo BioPharma Group plc's 2027 outlook centres on $0.3488, within a $0.2701 to $0.4807 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, MREO could reach as high as $0.5293, with a base case around $0.3661 and support toward $0.2728 — roughly +16% from $0.3155. Price action looks broadly range-bound.
Expect MREO to range from $0.2858 to $0.5941 through 2029. The $0.3961 average target implies a +26% move from current prices. That is up +8% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The MREO price prediction for 2030 points to an average of $0.5054 (low $0.3543, high $0.7815) — a potential gain of +60% on today's $0.3155. Momentum favours further upside here.
In 2031, MREO is projected to trade between $0.3949 and $0.9184, averaging $0.5784 — a potential gain of +83% from today's $0.3155. That is up +14% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Mereo BioPharma Group plc's 2032 outlook centres on $0.6175, within a $0.4114 to $1.00 range. That is up +7% on the projected 2031 average. That marks a +96% change versus current levels. Momentum favours further upside here.
By 2033, MREO could reach as high as $1.12, with a base case around $0.6757 and support toward $0.4398 — roughly +114% from $0.3155. Buyers look set to stay in control over this stretch.
Expect MREO to range from $0.3949 to $1.05 through 2034. The $0.6203 average target implies a +97% move from current prices. That is -8% versus the projected 2033 average. Momentum favours further upside here.
The MREO price prediction for 2035 points to an average of $0.6578 (low $0.4099, high $1.13) — a potential gain of +109% on today's $0.3155. Buyers look set to stay in control over this stretch.
In 2040, MREO is projected to trade between $0.5323 and $1.75, averaging $0.943 — a potential gain of +199% from today's $0.3155. That is up +43% on the projected 2035 average. Momentum favours further upside here.
Mereo BioPharma Group plc's 2050 outlook centres on $2.33, within a $1.10 to $4.82 range. That is up +147% on the projected 2040 average. That marks a +638% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in MREO today (≈ 3,169.572108 MREO) could be worth
$7,380.21
+$6,380.21 (+638%) by 2050 · US Dollar
Based on the average projected MREO price of $2.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MREOwould be worth at today's price.
$1,000 invested in MREO on Jul 31, 2025 (≈ 591.715956 MREO) would be worth
$186.69
-$813.31 (-81.3%) today · 0.19× · US Dollar
Based on a MREO entry price of $1.69 vs. today's $0.3155.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.288 | $1,095.49 | +9.5% |
| 1 month ago | $0.323 | $976.78 | -2.3% |
| 3 months ago | $0.26 | $1,213.46 | +21.3% |
| 6 months ago | $0.433 | $728.64 | -27.1% |
| 1 year ago | $1.69 | $186.69 | -81.3% |
| All time (5.0y) ago | $2.68 | $117.72 | -88.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MREO forecast.
Our base-case forecast reaches $0.63 around 2033.
Implied market cap at $0.63: $100.56M
In 2030, the forecast shows an average price of $0.5461 with a max of $0.8445 and a ROI of 59.4%; sentiment is BULLISH. In 2040, the forecast shows an average price of $1.02 with a max of $1.90 and a ROI of 198%; sentiment remains BULLISH. In 2050, the forecast shows an average price of $2.52 with a max of $5.20 and a ROI of 634.1%; sentiment remains BULLISH.
Taken together, the multi-year path points to a meaningful long-run upside, though these are estimates and carry inherent uncertainty.
Tap a question to reveal the answer.
2030 avg price $0.5461, min $0.3827, max $0.8445, ROI 59.4%, sentiment BULLISH.
The forecast shows potential upside with year-by-year increases (e.g., 2030 avg $0.5461 and 2050 avg $2.52 with max $5.20, ROI up to 634.1%), but these are estimates and carry uncertainty.
Yes. The forecast max reaches $1.09 in 2032, $1.21 in 2033, and $1.23 in 2035, with continued upside in later years (e.g., 2040 max $1.90, 2050 max $5.20).
Current price is $0.3427 and market cap is $54.7M.
The sentiment is BULLISH, RSI 60, SMA50 $0.3136, SMA200 $0.7771, with support at $0.288 and resistance at $0.343. The 30-day range is $0.2701–$0.4348.
Mereo BioPharma Group plc Community Discussion
0Share your Mereo BioPharma Group plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.